Target intelligence / Profile preview

Novel transcript, antisense to NKX2-4

Molecular classification
Other (non-coding RNA, antisense RNA), not a receptor, enzyme, transporter, transcription factor, or other canonical drug target class
01

Overview

Novel transcript, antisense to NKX2-4" (ENSG00000225280, LOC105372558) is a predicted or uncharacterized non-coding RNA transcribed from the DNA strand opposite to the NKX2-4 gene. It is cataloged in public databases for transcriptome completeness but is not known to encode a protein, nor is there published evidence of functional roles, involvement in disease, or use as a biomarker or drug target. Antisense transcripts can theoretically regulate adjacent genes via RNA-based mechanisms, but for ENSG00000225280, such functions have not been established or reported in the literature. The adjacent gene, NKX2-4, is a protein-coding homeobox transcription factor involved in development, but the antisense transcript "novel transcript, antisense to NKX2-4" remains uncharacterized in regard to function, clinical significance, or druggability[4]. The entry is likely retained in genome databases for annotation completeness but does not meet criteria for a structured therapeutic target or canonical molecular family. If you are seeking information about the protein-coding gene NKX2-4 (NK2 homeobox 4), that would be a different, well-annotated target[4].

Other names
ENSG00000225280LOC105372558novel transcript antisense to NKX2-4

Beyond the preview

Go deeper on Novel transcript, antisense to NKX2-4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to NKX2-4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call